StockData
Medtronic plc logo

Medtronic plc (MDT) operating KPIs

MDTNYSEElectromedical & Electrotherapeutic ApparatusFiscal year ends April 24
Financials through Q1 FY2027, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 3, 2026Score 19/303% below fair value
$96.54−0.57 (-0.59%)

Close on Oct 30, 2026Market cap $123.49BP/E 23.7Yield 2.94%

Medtronic respiratory, Gastrointestinal & Renal (Legacy through FY2023Q4) — Organic Revenue Growth YoY (%) (%)

Medtronic Form 8-K World-Wide Revenue Tables (Published Organic Growth)

QuarterlyAnnual
Latest, Q4 FY23
5.9%
Period ended Apr 30, 2023
Change on a year earlier
+10.0 pts
-4.1% in Q4 FY22
History
23 quarters
Since Q2 FY18
Sources
23
Documents cited below

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedRespiratory, Gastrointestinal & Renal (Legacy through FY2023Q4) — Organic Revenue Growth YoY (%) (%)Year on yearSource
Q4 FY23Apr 30, 20235.9%+10.0 ptsMedtronic SEC 8K_EARNINGS — FY2023Q4 (filed 2023-05-25) ↗
Q3 FY23Jan 31, 2023-3.0%+8.6 ptsMedtronic SEC 8K_EARNINGS — FY2023Q3 (filed 2023-02-21) ↗
Q2 FY23Oct 31, 2022-11.1%-0.6 ptsMedtronic SEC 8K_EARNINGS — FY2023Q2 (filed 2022-11-22) ↗
Q1 FY23Jul 31, 2022-9.1%-12.6 ptsMedtronic SEC 8K_EARNINGS — FY2023Q1 (filed 2022-08-23) ↗
Q4 FY22Apr 30, 2022-4.1%-5.0 ptsMedtronic SEC 8K_EARNINGS — FY2022Q4 (filed 2022-05-26) ↗
Q3 FY22Jan 31, 2022-11.6%-37.0 ptsMedtronic SEC 8K_EARNINGS — FY2022Q3 (filed 2022-02-22) ↗
Q2 FY22Oct 31, 2021-10.5%-40.2 ptsMedtronic SEC 8K_EARNINGS — FY2022Q2 (filed 2021-11-23) ↗
Q1 FY22Jul 31, 20213.5%-3.7 ptsMedtronic SEC 8K_EARNINGS — FY2022Q1 (filed 2021-08-24) ↗
Q4 FY21Apr 30, 20210.9%-6.8 ptsMedtronic SEC 8K_EARNINGS — FY2021Q4 (filed 2021-05-27) ↗
Q3 FY21Jan 31, 202125.4%+23.2 ptsMedtronic SEC 8K_EARNINGS — FY2021Q3 (filed 2021-02-23) ↗
Q2 FY21Oct 31, 202029.7%+23.6 ptsMedtronic SEC 8K_EARNINGS — FY2021Q2 (filed 2020-11-24) ↗
Q1 FY21Jul 31, 20207.2%-687.8 ptsMedtronic SEC 8K_EARNINGS — FY2021Q1 (filed 2020-08-25) ↗
Q4 FY20Apr 30, 20207.7%-742.3 ptsMedtronic SEC 8K_EARNINGS — FY2020Q4 (filed 2020-05-21) ↗
Q3 FY20Jan 31, 20202.2%-700.8 ptsMedtronic SEC 8K_EARNINGS — FY2020Q3 (filed 2020-02-18) ↗
Q2 FY20Oct 31, 20196.1%-656.9 ptsMedtronic SEC 8K_EARNINGS — FY2020Q2 (filed 2019-11-19) ↗
Q1 FY20Jul 31, 2019695.0%+692.0 ptsMedtronic SEC 8K_EARNINGS — FY2020Q1 (filed 2019-08-20) ↗

Cite this data

StockData. (2026). Medtronic Respiratory, Gastrointestinal & Renal (Legacy through FY2023Q4) — Organic Revenue Growth YoY (%) (%), quarterly Q2 FY18–Q4 FY23 [Data set]. Compiled from Medtronic SEC filings and investor materials. https://stockdatahq.com/stocks/mdt/kpis/ms-rgr-leg-ww-org

See every metric in the Medtronic KPI table. Data updated Oct 31, 2026.